TAS-102 in metastatic colorectal cancer (mCRC): efficacy, tolerability, and quality of life in heavily pretreated elderly patients: a real-life study

• Egile Nagusiak: Giuseppe Cicero (Egilea), Raffaele Addeo (Egilea), Rossella De Luca (Egilea), Giuseppe Lo Re (Egilea), Leonardo Gulotta (Egilea), Pierenrico Marchesa (Egilea), Gaspare Gulotta (Egilea)
• Formatua: Liburua
• Argitaratua: BioExcel Publishing Ltd, 2020-09-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Background: TAS-102 is an oral monotherapy, combining trifluridine and tipiracil hydrochloride, indicated for the treatment of pretreated metastatic colorectal cancer (mCRC). The aim of this real-life study is to evaluate the efficacy and safety of TAS-102 in heavily pretreated elderly patients with...